Recurrent hepatocellular carcinoma in liver transplant recipients with hepatitis C

Journal of Gastrointestinal Cancer

Volumn 43, Issue 2, 2012, Pages 229-235

  Zendejas Ruiz, Ivan ^b   Hemming, Alan W ^c   Chen, Chaoru ^b   Schwartz, Jason J ^a   Sorensen, John B ^a   Kim, Robin D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Hepatitis C; Hepatocellular cancer; Liver transplantation; Recurrence

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT CANCER;

CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 84863871271     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-010-9230-4     Document Type: Article

References (24)

1. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer. 1998;75(3):347-54. doi:10.1002/(SICI) 1097-0215(19980130) 75:3〈347::AID-IJC4〉3.0.CO;2-2.
2. El Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000;160(21):3227-30. doi:10.1001/archinte.160.21.3227.
3. El Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002;36(5 Suppl 1):S74-83. doi:10.1053/jhep.2002.36807.
4. Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002;36(5 Suppl 1):S30-4. doi:10.1053/jhep.2002.36791. (Pubitemid 35253461)
5. Charlton M. Hepatitis C infection in liver transplantation. Am J Transplant. 2001;1(3):197-203. doi:10.1034/j.1600-6143.2001.001003197.x. (Pubitemid 33674162)
6. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693-9. doi:10.1056/NEJM199603143341104. (Pubitemid 26079803)
7. Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, et al. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transplant. 2007;13(6):807-13. doi:10.1002/lt.21054. (Pubitemid 46947847)
8. Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg. 2003;238(3):315-21. doi:10.1097/01.sla.0000086548.84705.ef.
9. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg. 2003;238 (4):508-18. doi:10.1097/01.sla.0000090449.87109.44.
10. American Liver Tumor Study Group - A Randomized Prospective Multi-Institutional Trial of Orthotopic Liver Transplantation or Partial Hepatic Resection with or Without Adjuvant Chemotherapy for Hepatocellular Carcinoma. Investigators Booklet and Protocol; 1998.
11. Ishak K, Baptista A, Bianchi L, Callea F, De GJ, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-9. doi:10.1016/0168-8278(95)80226-6.
12. Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C. Liver Transplant. 2004;10(12):1478-86. doi:10.1002/lt.20303. (Pubitemid 40028380)
13. Min AD, Saxena R, Thung SN, Atillasoy EO, Wolf DC, Sauter B, et al. Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant. Am J Gastroenterol. 1998;93(11):2148-53. doi:10.1016/S0002-9270(98)00492-4. (Pubitemid 29076866)
14. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191(4):389-94. doi:10.1016/S1072-7515(00) 00688-8.
15. Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J, et al. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg. 2008;143(2):182-8. doi:10.1001/archsurg.2007.39. (Pubitemid 351281631)
16. Ghobrial RM, Shimoda M, Farmer DG, Yersiz H, Chen P, Dawson S, et al. Factors determining outcome of liver transplantation for hepatocellular carcinoma associated with hepatitis C cirrhosis. Transplant Proc. 2001;33(1-2):1358. doi:10.1016/S0041-1345(00)02509-4. (Pubitemid 32237880)
17. Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol. 1999;17(1):324-31. (Pubitemid 29022410)
18. Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, Dardano G, et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg. 1998;5(1):29-34. doi:10.1007/PL00009947. (Pubitemid 128662554)
19. Zavaglia C, De CL, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol. 2005;100 (12):2708-16. doi:10.1111/j.1572-0241. 2005.00289.x.
20. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233(5):652-9. doi:10.1097/00000658-200105000-00009. (Pubitemid 32378649)
21. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, et al. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transplant. 2004;10(10):1240-7. doi:10.1002/lt.20238. (Pubitemid 39406077)
22. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology. 2000;32(5):1125-30. doi:10.1053/jhep.2000.19340.
23. Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 1997;25(1):203-10. doi:10.1053/jhep.1997.v25.pm0008985291. (Pubitemid 27015011)
24. Mas VR, Fisher RA, Archer KJ, Yanek KC, Williams B, Dumur CI, et al. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results. Transplantation. 2007;83 (7):973-81. doi:10.1097/01.tp.0000258643. 05294.0b. (Pubitemid 46682740)